Alex J.

Alex J. has extensive experience in the pharmaceutical and healthcare industry. Alex began their career at GE Healthcare in 2000, where they held various research and development roles, specializing in the discovery and development of new PET and SPECT tracers. Alex then joined Theragnostics in 2020 as the Head of Research and Development, where they worked until 2023. Currently, they are serving as the Senior Director of CMC at Ariceum Therapeutics, where they started in 2023.

Alex J. completed their education from 1994 to 2000 at the University of Warwick. During this time, they earned a B.Sc. and Ph.D in Synthetic Chemistry and Medicinal Chemistry.